Menu

More Retractions for Tokyo Scientist?

A university panel has detected irregularities in 43 papers by Shigeaki Kato.

Jul 26, 2013
Kate Yandell

FLICKR, ROBERT CUDMOREA University of Tokyo panel is recommending that former university scientist Shigeaki Kato withdraw 43 scientific papers, according to the Asahi Shimbun, a Japanese newspaper.

The recommendations are the result of an investigation that was triggered last year (January 2012) when an anonymous tipster made a Youtube video chronicling allegedly fraudulent manipulations made to figures in Kato’s papers. Kato resigned from his position at the university in March 2012. According to Retraction Watch, five papers by Kato have already been retracted.

The University of Tokyo told ScienceInsider that the panel’s report has not yet been released and did not confirm the assertions made by Asahi Shumbun.

According to the Japanese newspaper, the committee reviewed 165 papers and found questionable material in 43 of them. The problems included duplicated and reversed images, as well as forgery.

Kato told Asahi Shumbun that he planned to withdraw the papers. “There certainly were irregularities,” he said. “I used to place trust on the members of my lab. I have a major responsibility as a supervisor.”

The Asahi Shumbun noted that some of Kato’s collaborators who got their degrees based on the questionable papers could have them revoked. More than 20 scientists were coauthors on the 43 papers.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.